SCHEMBL446749

SCHEMBL446749

CSC(=S)N(C)NS(=O)(=O)CC(=O)NN(C)C(=S)c1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 2/20 0.59
HSP90AB1 P08238 1/20 0.59
ALDH1A1 P00352 8/20 0.36
MAPT P10636 6/20 0.36
SMN1; SMN2 Q16637 4/20 0.33
RAB9A P51151 2/20 0.33
NPC1 O15118 1/20 0.33
CA2 P00918 1/20 0.33
KMT2A Q03164 4/20 0.32
L3MBTL1 Q9Y468 3/20 0.32
MEN1 O00255 3/20 0.32
HPGD P15428 2/20 0.32
GAA P10253 2/20 0.32
LMNA P02545 4/20 0.32
HTT P42858 3/20 0.32
NPSR1 Q6W5P4 2/20 0.32
ALOX12 P18054 1/20 0.32
HSD11B1 P28845 1/20 0.31
KDM4E B2RXH2 1/20 0.31
POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL464655 0.90 HSP90AA1 (0.68) HSP90AA1HSP90AB1ALDH1A1MAPTSMN1; SMN2
SCHEMBL446362 0.86 HSP90AA1 (0.63) HSP90AA1HSP90AB1ALDH1A1MAPTKMT2A
SCHEMBL445761 0.84 HSP90AA1 (0.59) HSP90AA1HSP90AB1ALDH1A1MAPTSMN1; SMN2
SCHEMBL445596 0.83 HSP90AA1 (0.59) HSP90AA1HSP90AB1ALDH1A1MAPTKMT2A
SCHEMBL446705 0.83 HSP90AA1 (0.31) HSP90AA1HSP90AB1
SCHEMBL445766 0.82 HSP90AA1 (0.58) HSP90AA1HSP90AB1ALDH1A1MAPTSMN1; SMN2
SCHEMBL449281 0.82 HSP90AA1 (0.54) HSP90AA1HSP90AB1ALDH1A1MAPTSMN1; SMN2
SCHEMBL10231455 0.81 HSP90AA1 (0.46) HSP90AA1HSP90AB1ALDH1A1MAPTSMN1; SMN2
SCHEMBL448046 0.81 HSP90AA1 (0.56) HSP90AA1HSP90AB1ALDH1A1MAPTSMN1; SMN2
SCHEMBL447212 0.81 HSP90AA1 (0.56) HSP90AA1HSP90AB1ALDH1A1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8680100-B2 Sulfonylhydrazide compounds for treating proliferative disorders SYNTA PHARMACEUTICALS CORP. (US) 2014-03-25 US disclosed
US-8680100-B2 Sulfonylhydrazide compounds for treating proliferative disorders SYNTA PHARMACEUTICALS CORP. (US) 2014-03-25 US disclosed
US-20120065206-A1 COMPOUNDS FOR TREATING PROLIFERATIVE DISORDERS SYNTA PHARMACEUTICALS CORP. (US) 2012-03-15 US disclosed
US-20120065206-A1 COMPOUNDS FOR TREATING PROLIFERATIVE DISORDERS SYNTA PHARMACEUTICALS CORP. (US) 2012-03-15 US disclosed
EP-2370402-A2 COMPOUNDS FOR TREATING PROLIFERATIVE DISORDERS Synta Pharmaceuticals Corp. (US) 2011-10-05 EP disclosed
WO-2010065512-A2 COMPOUNDS FOR TREATING PROLIFERATIVE DISORDERS SYNTA PHARMACEUTICALS CORP. (US) 2010-06-10 WO disclosed
WO-2010065512-A2 COMPOUNDS FOR TREATING PROLIFERATIVE DISORDERS SYNTA PHARMACEUTICALS CORP. (US) 2010-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120065206-A1 COMPOUNDS FOR TREATING PROLIFERATIVE DISORDERS PKD1, PKD2, PCNA HSP90AA1 2300/4885HSP90AB1 1711/4885ALDH1A1 1351/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.